We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiopulmonary Bypass (CPB) Pumps and Blood Activation

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by University Hospital, Angers.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00187967
First Posted: September 16, 2005
Last Update Posted: September 26, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Angers
  Purpose
Blood activation induced by cardiopulmonary bypass may compromise the postoperative outcome. The goal of this study is to compare blood activation induced by cardiopulmonary bypass performed with centrifugal pump or roller pump in patients undergoing coronary artery surgery.

Condition Intervention
Cardiopulmonary Bypass Coronary Artery Disease Device: pumps used for cardiopulmonary bypass

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps

Further study details as provided by University Hospital, Angers:

Study Start Date: January 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Men undergoing coronary artery bypass grafting using cardiopulmonary bypass
  • Aspirin therapy

Exclusion Criteria:

  • Redo surgery
  • Acute coronary syndrome requiring urgent surgery
  • Oral anticoagulant therapy
  • Organ dysfunction or chronic inflammatory disease
  • Surgery other than coronary artery bypass grafting
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00187967


Contacts
Contact: Anthony Bailleul 33-(0)2-41-35-58-91

Locations
France
University Hospital of Angers Recruiting
Angers, France, 49933
Contact: Christophe Baufreton, MD, PhD    33-(0)2-41-35-45-73    ChBaufreton@chu-angers.fr   
Contact: Anthony Bailleul    33-(0)2-41-35-58-91      
Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Christophe Baufreton, MD, PhD University Hospital of Angers, France
  More Information

ClinicalTrials.gov Identifier: NCT00187967     History of Changes
Other Study ID Numbers: PHRC 03-03
First Submitted: September 9, 2005
First Posted: September 16, 2005
Last Update Posted: September 26, 2007
Last Verified: September 2005

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases